HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chi-Chou Huang Selected Research

XAV939

4/2016DDX3 enhances oncogenic KRAS‑induced tumor invasion in colorectal cancer via the β‑catenin/ZEB1 axis.
2/2016DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.
1/2016Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chi-Chou Huang Research Topics

Disease

18Neoplasms (Cancer)
01/2022 - 06/2005
18Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2006
3Carcinogenesis
01/2021 - 06/2007
3Colonic Neoplasms (Colon Cancer)
04/2016 - 01/2016
2Neoplasm Metastasis (Metastasis)
12/2019 - 07/2016
2Carcinoma (Carcinomatosis)
06/2007 - 06/2005
1Virus Diseases (Viral Diseases)
02/2018
1Lymphatic Metastasis
12/2016
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2016
1Hyperalgesia
10/2016
1Pain (Aches)
10/2016
1Stomach Neoplasms (Stomach Cancer)
10/2016
1Peripheral Nervous System Diseases (PNS Diseases)
10/2016
1Triple Negative Breast Neoplasms
07/2016
1Breast Neoplasms (Breast Cancer)
07/2016
1Nausea
02/2015
1Vomiting
02/2015
1Dermatitis
10/2013
1Exanthema (Rash)
10/2013
1Pyogenic Liver Abscess
01/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2013
1Infections
08/2012
1Abscess
11/2011
1Coinfection
06/2009
1Leukopenia
06/2009

Drug/Important Bio-Agent (IBA)

5CateninsIBA
05/2018 - 10/2014
4Proteins (Proteins, Gene)FDA Link
02/2016 - 08/2006
3XAV939IBA
04/2016 - 01/2016
2Fluorouracil (Carac)FDA LinkGeneric
05/2018 - 02/2015
2carfilzomibIBA
05/2018 - 01/2016
2Cetuximab (Erbitux)FDA Link
01/2017 - 10/2013
2Pharmaceutical PreparationsIBA
10/2016 - 10/2013
2p38 Mitogen-Activated Protein KinasesIBA
06/2007 - 06/2005
1Carbonic Anhydrase IXIBA
01/2022
1Type 4 Fibroblast Growth Factor ReceptorIBA
05/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2021
1H-cadherin (T-cadherin)IBA
01/2021
1delphinidinIBA
12/2019
1IntegrinsIBA
12/2019
1ribonucleotide reductase M2IBA
05/2018
1Transcription Factors (Transcription Factor)IBA
02/2018
1Glycoproteins (Glycoprotein)IBA
02/2018
1Calcibiotic Root Canal SealerIBA
01/2017
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2016
1Connective Tissue Growth FactorIBA
07/2016
1perifosineIBA
04/2016
13- (3- chlorophenoxymethyl)- 1- (tetrahydropyran- 4- yl)- 1H- pyrazolo(3,4- d)pyrimidin- 4- ylamineIBA
02/2016
1ThrombomodulinIBA
01/2016
1ezrinIBA
01/2016
1VimentinIBA
01/2016
1Fibronectins (Fibronectin)IBA
01/2016
1Serine (L-Serine)FDA Link
04/2015
1PaxillinIBA
04/2015
1Capecitabine (Xeloda)FDA Link
02/2015
1Leucovorin (Folinic Acid)FDA Link
02/2015
1Phosphotransferases (Kinase)IBA
12/2014
1ErbB Receptors (EGF Receptor)IBA
10/2013
1Irinotecan (Camptosar)FDA LinkGeneric
10/2013
1Messenger RNA (mRNA)IBA
08/2012
1Oncogene Proteins (Oncogene Protein)IBA
08/2012
1DNA (Deoxyribonucleic Acid)IBA
08/2012
1ProstaglandinsIBA
09/2010
1Prostaglandins EIBA
09/2010
1Glycogen Synthase Kinase 3 betaIBA
09/2010
1citronellolIBA
06/2009
1AminesIBA
07/2007
1protocatechuic acidIBA
06/2007
1Antineoplastic Agents (Antineoplastics)IBA
06/2005
1PolyphenolsIBA
06/2005

Therapy/Procedure

4Drug Therapy (Chemotherapy)
12/2016 - 06/2009
4Therapeutics
07/2016 - 06/2009
2Adjuvant Chemotherapy
12/2016 - 02/2015
2Catheters
01/2013 - 11/2011
1Lasers (Laser)
10/2016
1Aftercare (After-Treatment)
02/2015
1Radiotherapy
06/2009